News
Umbilical Cord Blood for Knee Joint Cartilage Issues: A Review
Umbilical Cord Blood for Knee Joint Cartilage Issues: A Review Umbilical cord blood mesenchymal stem cell transplantation as a novel method for repairing knee joint cartilage has shown promising results in clinical settings, providing an effective treatment option for patients with these issues. A new review of the clinical research into the use of umbilical…
A New Frontier: Cord Blood Stem Cells in the Treatment of Crohn’s Disease
A New Frontier: Cord Blood Stem Cells in the Treatment of Crohn’s Disease A groundbreaking study has explored the potential of using autologous cord blood stem cells for treating refractory Crohn’s Disease – a condition where standard treatments fail to manage symptoms. The trial evaluated the long-term effects of using a patient’s own stored cord…
FDA Approves Stem Cell Treatment for Dogs and Horses
A New FDA-approved clinical trial at Cornell University Hospital for Animals is exploring how stem cells can treat various musculoskeletal and neurological conditions in both dogs and horses. The trial focuses on using stem cells to help heal tissue, reduce inflammation, and manage pain in conditions like osteoarthritis, tendinopathy, and hip and elbow dysplasia. The…
Saved by his own cord blood – 19 years later
When Xiao An was diagnosed with severe aplastic anemia at age 18, his parents were grateful for a decision they’d made at his birth – storing his cord blood stem cells. The teenager had suddenly developed symptoms including ulcers and blood spots. Tests revealed he had aplastic anemia, a serious autoimmune condition where the body…
Picky eaters? Blame their genes
New research from King’s College London in collaboration with UCL and University of Leeds suggests that food fussiness is largely genetic. For parents struggling with picky eaters, this research offers some relief, confirming that genes play a bigger role than previously thought. Lead author of the study, Zeynep Nas said he hoped the findings may…
Cord blood hope for bowel disease
In a groundbreaking study researchers have demonstrated the potential of human umbilical cord blood mononuclear cells (HUCB-MNCs) in treating ischemic bowel disease (ICBD). ICBD, a group of intestinal ischemia syndromes caused by reduced blood flow, has been notoriously difficult to diagnose and treat. With mortality rates as high as 50-80% for acute cases, the need…
Cord blood hope for preemies
Cord blood stem cells may hold the key to preventing Retinopathy of Prematurity (ROP) – a major cause of irreversible blindness in preterm newborns. ROP results from abrupt alterations in oxygen levels impacting the retina’s development. Standard treatment involves transfusions of packed red blood cells from adult donors. However, this can lead to a rapid…
27 years and counting
A new study shows cord blood stem cell remain viable after 27 years of cryogenic storage. The research, conducted at the US based laboratory of the late cord blood pioneer Hal Broxmeyer, extends the facility’s previous findings on cord blood’s longevity, when tested at 5, 10, 15, and 23.5 years. See the study here. According…
‘The Business of Happily Ever Afters’ NZBusiness Mag
Many years into running my PR company, I couldn’t imagine doing anything else. I loved the clients, my team, and the media (mostly). But learning about cord blood banking set me on a new and unexpected path. Now, 20 years after I co-founded CordBank Aotearoa’s first – and still only – cord blood bank. –…
Stem cells for glaucoma treatment?
Stem cells for glaucoma treatment? As March is NZ Glaucoma Awareness Month, it’s timely to recognise that around 2% of New Zealanders over 40 years of age have glaucoma – a group of eye conditions that damage the optic nerve. Now, stem cells are being investigated as a possible treatment. Read more about this research…